Atrs stock price target

Expensive Market, What To Buy? Cara Therapeutics Inc ... Mar 09, 2020 · Their price target on the stock stands at $3.50. H.C. Wainwright also rated ATRS as Initiated on June 23, 2017, with its price target of $5 suggesting that ATRS could surge by 50.15% from its current share price. Even though the stock has been trading at $3.47/share, analysts expect it to down by -6.63% to reach $6.50/share. Antares Pharma, Inc. (NASDAQ:ATRS) - Raymond James ...

Analysts Are Bullish on These Healthcare Stocks: Antares ... There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Antares Pharma (ATRS – Research Report) and Durect (DRRX – Research Report) with bullish sentiments.Antares Pharma (ATRS) In a report released today, Oren Livnat from H.C. Wainwright reiterated a Buy rating on Antares Pharma, with a price target of $5.00. Brokerages Expect Antares Pharma Inc (NASDAQ:ATRS) Will ... One equities research analyst has rated the stock with a hold rating, two have given a buy rating and two have given a strong buy rating to the company’s stock. The company currently has an average rating of “Buy” and an average price target of $4.05. ATRS opened at $4.70 on Wednesday. The company has a quick ratio of 2.46, a current Here’s Why Antares Pharma, Inc. (ATRS) Is A Stock To Set ... On Monday, shares of Antares Pharma, Inc. (NASDAQ:ATRS) marked $3.62 per share versus a previous $3.67 closing price. With having a -1.36% loss, an insight into the fundamental values of Antares Pharma, Inc., investors would also find a great ally in the technical patterns of the stock movements showed in stock …

Dec 05, 2019 · ATRS stock reached 52-week highs on December at $5.13, and all-time highs 1997-01-23 with a price of 31.88. ATRS stock price target How much a stock will be priced tomorrow or next week is quite unpredictable However, many stock price predictions are published every day by banks, financial institutions and independent analysts.

Antares Pharma, Inc. Common Stock (ATRS) Real-Time Stock ... ATRS's NASDAQ Last Sale (NLS) "Last Sale" is the price at which a stock last traded during regular market hours. NLS Volume "Volume" is the number of shares of the stock traded on the listing exchange during regular trading hours. Previous Close Today's High / Low 52 Week High / Low ANTARES PHARMA, INC. : Target Price Consensus and Analysts ... Mean consensus: BUY: Number of Analysts: 6: Average target price: 6,50 $ Last Close Price: 2,09 $ Spread / Highest target

Antares Pharma, Inc. (NASDAQ:ATRS) Upgrades/Downgrades …

Based on 1 analyst offering 12 month price targets for ATRS in the last 3 months. The average price target is $4.50 with a high estimate of $4.50 and a low estimate of $4.50. ATRS | Antares Pharma Inc. Analyst Estimates & Rating – WSJ ATRS updated stock price target summary. Dow Jones, a News Corp company. News Corp is a network of leading companies in the worlds of diversified media, news, education, and information services. ATRS Stock Price, Forecast & News (Antares Pharma) 2 brokerages have issued 12 month price targets for Antares Pharma's stock. Their forecasts range from $5.00 to $6.00. On average, they anticipate Antares Pharma's stock price to reach $5.50 in the next twelve months. This suggests a possible upside of 172.3% from the stock's current price. View analysts' price targets for Antares Pharma. Antares Pharma, Inc. Common Stock (ATRS) Analyst Research ... Based on analysts offering 12 month price targets for ATRS in the last 3 months. The average price target is $ 0.00 with a high estimate of $ 0.00 and a low estimate of $ 0.00.

Historical daily share price chart and data for Antares Pharma since 1996 adjusted for splits. The latest closing stock price for Antares Pharma as of April 06 , 

Aug 17, 2018 · Today, HC Wainwright set its price target on Antares Pharma Inc (NASDAQ:ATRS) to $5.00 per share. There are 2 Buy Ratings, no Strong Buy Ratings, no Sell Ratings, no Hold Ratings on the stock. ATRS - Antares Pharma, Inc. Summary, Stock Quote and News ... Jan 01, 2010 · Antares Pharma, Inc. (NASDAQ: ATRS) stock research, profile, news, analyst ratings, key statistics, fundamentals, stock price, charts, earnings, guidance and peers on ATRS:Vienna Stock Quote - Atrium European Real Estate Ltd ... Stock analysis for Atrium European Real Estate Ltd (ATRS:Vienna) including stock price, stock chart, company news, key statistics, fundamentals and company profile. Antares Pharma, Inc. - TheStreet

The average price target is $1.80 with a high forecast of $3.00 and a low forecast of $1.00. The average price target represents a 10.43% increase from the last price of $1.63. Go Pro

Antares Pharma, Inc. (ATRS) Stock Analysis & News ... Get breaking news and analysis on Antares Pharma, Inc. (ATRS) stock, price quote and chart, trading and investing tools. Get breaking news and analysis on Antares Pharma, Inc. (ATRS) stock, price

ATRS | Antares Pharma Inc. Analyst Estimates | MarketWatch Nov 09, 2019 · Antares Pharma Inc. analyst estimates by MarketWatch. View ATRS revenue estimates and earnings estimates, as well as analyst recommendations. ATRS - Antares Pharma Inc Stock quote - CNNMoney.com